Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use doxorubicin hydrochloride safely and effectively. See full prescribing information for doxorubicin hydrochloride injection. DOXORUBICIN hydrochloride injection, USP for intravenous use Initial U.S. Approval: 1974
Medication labelWhy this: Advisory · dailymed-prescription
DOXOrubicin hydrochloride injection, USP is indicated as a c omponent of multi-a gent adjuvant chemotherapy for treat ment of wo men with axillary lymph node involve ment following resection of pri mary breast cancer [see Clinical Studies (14.1 ) ]. DOXOrubicin hydrochloride injection, USP is indicated for the treat ment of acute ly mphoblastic leu ke mia acute m yeloblastic leuke mia Hodgkin lympho ma non-Hodgkin ly mpho ma (NHL) metastatic breast cancer metastatic Wil ms’ tumor metastatic neurobla stoma metastatic s oft tissue sa rco ma metastatic bone sarco ma metastatic o varian car cino ma metastatic t ransitional c ell bladder carcino ma metastatic t hyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma
- generic_name
- doxorubicin hydrochloride
- product_names
- DOXOrubicin Hydrochloride
- ndc
- 62756-826, 62756-827, 62756-826-40, 62756-827-40
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en